Harvard Management Company’s Generation Bio GBIO Stock Holding History

Harvard Management Company’s Portfolio GBIO Stock Details GBIO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-51,035	Closed	-$2.81M	–	25
2023 Q2	$2.81M	Hold	51,035	–	–	0.28%	19
2023 Q1	$2.19M	Hold	51,035	–	–	0.23%	31
2022 Q4	$2.01M	Hold	51,035	–	–	0.25%	32
2022 Q3	$2.71M	Hold	51,035	–	–	0.34%	31
2022 Q2	$3.35M	Hold	51,035	–	–	0.39%	28
2022 Q1	$3.75M	Hold	51,035	–	–	0.38%	33
2021 Q4	$3.61M	Hold	51,035	–	–	0.34%	39
2021 Q3	$12.8M	Sell	51,035 -200	-0.4%	-$47.9K	0.75%	20
2021 Q2	$13.8M	Hold	51,235	–	–	0.79%	21
2021 Q1	$14.6M	Sell	51,235 -911	-2%	-$292K	0.81%	22
2020 Q4	$14.8M	Buy	52,146 +1,519	+3%	+$488K	0.8%	15
2020 Q3	$15.6M	Hold	50,627	–	–	0.86%	13
2020 Q2	$10.6M	Buy	+50,627	New	+$11.3M	0.91%	12

Other funds holding GBIO

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

AVLSA

Atlas Venture Life Science Advisors Cambridge, Massachusetts $790M AUM 223.66% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return

PHS

PFM Health Sciences San Francisco, California $1.1B AUM 57.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return

Harvard Management Company's GBIO Position: Q3 2023 in Review

Harvard Management Company sold out of Generation Bio (GBIO) in Q3 2023, closing a stake of 51,035 shares — an estimated $2.81M sold.

Harvard Management Company first reported a position in GBIO in Q2 2020 and held it in 13 quarters. The position peaked at $15.6M in Q3 2020. 75 funds tracked by Wall St. Rank hold GBIO as of Q3 2023.

Harvard Management Company reported no remaining Generation Bio position as of Q3 2023 after selling out during the quarter.
Harvard Management Company sold 51,035 Generation Bio shares in Q3 2023, an estimated $2.81M.
Harvard Management Company first reported a position in Generation Bio in Q2 2020 and held it in 13 quarters.
Harvard Management Company's Generation Bio position peaked at $15.6M in Q3 2020.
75 funds tracked by Wall St. Rank held Generation Bio as of Q3 2023.

Based on Harvard Management Company's 13F filing for Q3 2023, filed 9 Nov 2023.